Downregulation of CD36 impaired phagocytic capacity and is associated with a proinflammatory phenotype of <i>Mst1</i> deficiency macrophages. حسب Jianyang Li (461703)

Mst1 knockout or suppressing its kinase activity increases the production of inflammatory mediators by activating the NF-κB pathway. حسب Jianyang Li (461703)

Microplastics Influence Dissolved Organic Matter Transformation Mediated by Microbiomes in Soil Aggregates حسب Xinran Qiu (9182255)

<i>japonicum</i> infection induces MST1 activation. حسب Jianyang Li (461703)

MST1 upregulates CD36 expression via PPARγ. حسب Jianyang Li (461703)

MST1was downregulated in macrophages from fibrotic livers of <i>S</i>. <i>japonicum</i>-infected mice and SEA-treated RAW264.7 cells. حسب Jianyang Li (461703)

Data Sheet 1_Polyphenol-mediated microbiome modulation in STEMI patients: a pilot study.zip حسب Argul Issilbayeva (21398168)

"…</p>Conclusion<p>Our findings demonstrate that polyphenol supplementation maintains stable TMAO levels by restructuring gut microbiome composition in STEMI patients, evidenced by a more focused microbiome with a significant increase in beneficial butyrate-producing bacteria (Roseburia, Agathobaculum sp., Alistipes finegoldii, and Sellimonas) and a decreased Firmicutes/Bacteroidetes ratio, suggesting microbiome-mediated cardioprotective effects. …"

Rescue of <i>pbp1</i>-KD phenotypes using CRISPRi trans-complementation. حسب Gregory A. Harrison (16639446)

Interpretation of findings of the present study. حسب Rayane Brinck Teixeira (6676529)

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... حسب Gyeong Ho Baek (21382907)

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... حسب Gyeong Ho Baek (21382907)

Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... حسب Gyeong Ho Baek (21382907)

Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... حسب Gyeong Ho Baek (21382907)

Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... حسب Gyeong Ho Baek (21382907)

Data Sheet 1_Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers.xlsx حسب Wentong Li (492392)

Data Sheet 5_Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers.csv حسب Wentong Li (492392)

Supplementary file 1_Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers.docx حسب Wentong Li (492392)

Data Sheet 2_Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers.xlsx حسب Wentong Li (492392)

Data Sheet 3_Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers.xlsx حسب Wentong Li (492392)

Data Sheet 4_Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers.xlsx حسب Wentong Li (492392)